Florida Cancer Specialists & Research Institute (FCS)
    Research facility
    
    
        Location: 
        Wellington,
        
                United States (USA) (US)
                
    
 
        
    
    
        ISNI: 0000000405045021
    
    
        ROR: https://ror.org/02px37122
    
    
        
            
                Show on Map:
                
                    
                
            
        
    
    
    
    
        
    
        
    
        
    
    
    
        
            
                
  
  Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial (2023)
  Rugo HS, Im SA, Cardoso F, Cortes J, Curigliano G, Musolino A, Pegram MD, et al.
  Journal article
            
                
  
  Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial (2021)
  Rugo HS, Im SA, Cardoso F, Cortes J, Curigliano G, Musolino A, Pegram MD, et al.
  Journal article